Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


02.05.2022

8 Aliment Pharmacol Ther
4 BMC Gastroenterol
1 Dig Dis Sci
4 Gastroenterology
1 Gut
6 Inflamm Bowel Dis
2 J Clin Gastroenterol
1 J Pediatr
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. VERSTOCKT B, Volk V, Jaeckel C, Alsoud D, et al
    Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis.
    Aliment Pharmacol Ther. 2022 Apr 28. doi: 10.1111/apt.16955.
    PubMed         Abstract available

  2. VANDE CASTEELE N, Sandborn WJ, Feagan BG, Vermeire S, et al
    Real-world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure-response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study.
    Aliment Pharmacol Ther. 2022 Apr 27. doi: 10.1111/apt.16937.
    PubMed         Abstract available

  3. WANG J, Goren I, Rieder F
    Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease. Authors' reply.
    Aliment Pharmacol Ther. 2022;55:1360.
    PubMed        

  4. FERNANDES RG, Radford-Smith G
    Editorial: is older-onset ulcerative colitis more severe or less aggressively managed?
    Aliment Pharmacol Ther. 2022;55:1350-1351.
    PubMed        

  5. RADEKE HH, Stein J
    Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2022;55:1359.
    PubMed        

  6. OKABAYASHI S, Yamazaki H, Matsuoka K, Yamamoto Y, et al
    Editorial: is older-onset ulcerative colitis more severe or less aggressively managed? Authors' reply.
    Aliment Pharmacol Ther. 2022;55:1352-1353.
    PubMed        

  7. BERGQVIST V, Holmgren J, Klintman D, Marsal J, et al
    Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2022 Apr 25. doi: 10.1111/apt.16927.
    PubMed         Abstract available

  8. HALFVARSON JF, Ludvigsson JF, Bresso F, Askling J, et al
    Age determines the risk of familial inflammatory bowel disease-A nationwide study.
    Aliment Pharmacol Ther. 2022 Apr 22. doi: 10.1111/apt.16938.
    PubMed         Abstract available


    BMC Gastroenterol

  9. BAYOUMY AB, van Liere ELSA, Simsek M, Warner B, et al
    Correction to: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom.
    BMC Gastroenterol. 2022;22:208.
    PubMed        

  10. NEGM M, Bahaa A, Farrag A, Lithy RM, et al
    Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study.
    BMC Gastroenterol. 2022;22:203.
    PubMed         Abstract available

  11. HIRAYAMA H, Morita Y, Imai T, Takahashi K, et al
    Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn's disease.
    BMC Gastroenterol. 2022;22:195.
    PubMed         Abstract available

  12. PARRA RS, Chebli JMF, Queiroz NSF, Damiao AOMC, et al
    Long-term effectiveness and safety of ustekinumab in bio-naive and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian study.
    BMC Gastroenterol. 2022;22:199.
    PubMed         Abstract available


    Dig Dis Sci

  13. FAN Y, Delgado-Aros S, Valdecantos WC, Janak JC, et al
    Characteristics of Patients with Crohn's Disease With or Without Perianal Fistulae in the CorEvitas Inflammatory Bowel Disease Registry.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07491.
    PubMed         Abstract available


    Gastroenterology

  14. SCHWARZLER J, Mayr L, Vich Vila A, Grabherr F, et al
    PUFA-Induced Metabolic Enteritis as a Fuel for Crohn's Disease.
    Gastroenterology. 2022;162:1690-1704.
    PubMed         Abstract available

  15. SHODA T, Collins MH, Rochman M, Wen T, et al
    Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study.
    Gastroenterology. 2022;162:1635-1649.
    PubMed         Abstract available

  16. SANDBORN WJ, D'Haens GR, Reinisch W, Panes J, et al
    Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
    Gastroenterology. 2022;162:1650-1664.
    PubMed         Abstract available

  17. SABINO J
    Understanding the Role of PUFAs in Crohn's Disease.
    Gastroenterology. 2022;162:1590-1591.
    PubMed        


    Gut

  18. LIN S, Lau LH, Chanchlani N, Kennedy NA, et al
    Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
    Gut. 2022 Apr 27. pii: gutjnl-2021-326784. doi: 10.1136/gutjnl-2021-326784.
    PubMed         Abstract available


    Inflamm Bowel Dis

  19. NELSON AD, Elkins JR, Stocchi L, Farraye FA, et al
    Use and Misuse of Parenteral Nutrition in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574514. doi: 10.1093.
    PubMed         Abstract available

  20. TORTORA C, Di Paola A, Creoli M, Argenziano M, et al
    Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574513. doi: 10.1093.
    PubMed         Abstract available

  21. FRIEDMAN S, Zegers FD, Jolving LR, Nielsen J, et al
    Increased Risk of Postpartum Infections After Caesarian and Vaginal Delivery in Women With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574515. doi: 10.1093.
    PubMed         Abstract available

  22. KWON JY, Daoud ND, Hashash JG, Picco MF, et al
    Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 25. pii: 6573907. doi: 10.1093.
    PubMed         Abstract available

  23. VELOSO FT
    Are Ulcerative Colitis and Diverticulitis Connected by the Same Hub?
    Inflamm Bowel Dis. 2022 Apr 23. pii: 6573214. doi: 10.1093.
    PubMed        

  24. HASAN B, Ur Rahman A
    Ulcerative Colitis and Diverticulitis Are Possibly Connected to the Same Hub.
    Inflamm Bowel Dis. 2022 Apr 23. pii: 6573283. doi: 10.1093.
    PubMed        


    J Clin Gastroenterol

  25. KIM ES, Kim SK, Park DI, Kim HJ, et al
    Comparison of the Pharmacokinetics of CT-P13 Between Crohn's Disease and Ulcerative Colitis.
    J Clin Gastroenterol. 2022 Apr 26. pii: 00004836-990000000-00020.
    PubMed         Abstract available

  26. AGGARWAL M, Alkhayyat M, Abou Saleh M, Sarmini MT, et al
    Alzheimer Disease Occurs More Frequently In Patients With Inflammatory Bowel Disease: Insight From a Nationwide Study.
    J Clin Gastroenterol. 2022 Apr 21. pii: 00004836-990000000-00017.
    PubMed         Abstract available


    J Pediatr

  27. MILLER TL, Schuchard J, Carle AC, Forrest CB, et al
    Use of Patient-Reported Outcomes Measurement Information System Pediatric Measures as Clinical Trial Endpoints: Experience from a Multicenter Pragmatic Trial in Children with Crohn's Disease.
    J Pediatr. 2022;242:86-92.
    PubMed         Abstract available


    PLoS One

  28. WAKAI M, Hayashi R, Ueno Y, Onishi K, et al
    Promoting mechanism of serum amyloid a family expression in mouse intestinal epithelial cells.
    PLoS One. 2022;17:e0264836.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: